• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Neurology

Early treatment of seizures in newborns associated with decreased seizure burden and frequency.

byBipandeep AbbatandAlex Chan
October 11, 2021
in Neurology, Pediatrics
Reading Time: 2 mins read
Share on FacebookShare on Twitter

Neonatal seizure management – Is the timing of treatment critical?

1. In a cohort of newborn infants, treatment of seizures within an hour of seizure recognition was associated with decreased seizure burden and decreased number of total seizures over the next 24 hours. 

Evidence Rating Level: 2 (Good)

Seizures are a leading cause of hypoxic-ischemic encephalopathy in newborn infants. Thus, current guidelines recommend antiseizure medication as soon as possible following seizure recognition, however, there are no specific guidelines on target treatment times. Therefore, this retrospective cohort study aimed to assess the impact of the time to treatment of the first electrographic seizure. It utilized data from two European multicentre cohort studies and included a total of 472 participants, of which 154 (32.6%) had seizures, confirmed with an electroencephalogram. From these participants, 69 were exclusively treated after onset of the electrographic seizures and this was the cohort analysed in the study. 21 infants received antiseizure medication within 1 hour, 15 infants between 1-2 hours, and 33 infants after 2 hours of seizure onset. The primary outcome measured was seizure burden (duration of all seizures during the monitoring period of 24 hours following initial seizure onset). It was found that infants treated with antiseizure medication within 1 hour had significantly lower seizure burden compared to the group that received medication after 2 hours of onset (36 minutes vs 75 minutes; p=0.029). The secondary outcomes measured were maximum seizure burden, presence of status epilepticus, number of seizures and total number of antiseizure medication doses. It was found that infants that received medication within 1 hour had decreased number of seizures compared to those who received medication after 2 hours (10 vs 28; p=0.035). There were no statistically significant differences in any other secondary outcomes. Therefore, the study concluded that there may be greater benefit to treating infants with antiseizure medication within 1 hour of electrographic seizures. However, larger prospective studies are needed to further validate these results.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Ecopipam reduces relapse risk in pediatric Tourette syndrome

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Tags: neurologypediatric neurologypediatricsSeizure
Previous Post

2 Minute Medicine Rewind, October 12, 2021

Next Post

Camrelizumab with apatinib is a well-tolerated treatment for chemo-refractory or relapsed gestational trophoblastic neoplasia

RelatedReports

Neurology

Ecopipam reduces relapse risk in pediatric Tourette syndrome

September 16, 2026
Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
Next Post
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Camrelizumab with apatinib is a well-tolerated treatment for chemo-refractory or relapsed gestational trophoblastic neoplasia

Children’s hospital visits for suicide ideation and attempts are increasing

Sexual minority youth report earlier age of onset and faster progression of suicidal ideation

Preterm birth associated with lower high school academic performance

Psychological counselling offered by postsecondary institutions may decrease student distress and increase grade point average  

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.